Methicillin-resistant Staphylococcus aureus in children with atopic dermatitis from 1999 to 2014: A longitudinal

Cassandra Chaptini1, Steve Quinn2, Gillian Marshman3

  • 1Flinders Medical Centre, Adelaide, South Australia, Australia.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is increasing in children with atopic dermatitis (AD) in Australia. This rise in MRSA poses significant health risks for affected children and the wider community.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Public Health

Background:

  • Rising rates of methicillin-resistant Staphylococcus aureus (MRSA) skin infections in the general population.
  • Limited research on MRSA prevalence specifically within the atopic dermatitis (AD) population.
  • Absence of prior MRSA prevalence studies in Australian paediatric AD patients.

Purpose of the Study:

  • To investigate the prevalence of MRSA and other bacterial organisms in children diagnosed with atopic dermatitis (AD).
  • To analyze trends in MRSA prevalence in this population over a 15-year period (1999-2014).
  • To identify potential associations between MRSA and patient factors such as hospital admissions.

Main Methods:

  • Retrospective analysis of skin swab results and patient data for 298 children (aged 0-18 years) with AD.
  • Data collected from a large teaching hospital in South Australia between 1999 and 2014.
  • Logistic regression used to assess changes in prevalence of MRSA, methicillin-sensitive S. aureus (MSSA), and Streptococcus spp. over time.

Main Results:

  • A significant increase in MRSA prevalence was observed over the study period, with likelihood increasing from approximately threefold to 24-fold.
  • Positive association found between the number of prior hospital admissions and MRSA positivity (OR=1.16).
  • No significant changes in the prevalence of MSSA or Streptococcus spp. were detected over the 15 years.

Conclusions:

  • The prevalence of MRSA in children with atopic dermatitis is demonstrably increasing.
  • This trend has adverse implications for individual patient health and represents a growing public health concern.
  • Further research and public health strategies are warranted to address rising MRSA rates in this vulnerable population.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...